ANTISENSE SRC EXPRESSION INHIBITS TYROSINE PHOSPHORYLATION OF SHC ANDITS ASSOCIATION WITH GRB2 AND SOS WHICH LEADS TO MAP KINASE ACTIVATION IN U937 HUMAN LEUKEMIA-CELLS
Citation
M. Yamaguchi et al., ANTISENSE SRC EXPRESSION INHIBITS TYROSINE PHOSPHORYLATION OF SHC ANDITS ASSOCIATION WITH GRB2 AND SOS WHICH LEADS TO MAP KINASE ACTIVATION IN U937 HUMAN LEUKEMIA-CELLS, Leukemia, 11(4), 1997, pp. 497-503
Categorie Soggetti
Hematology,Oncology
SICI code
0887-6924(1997)11:4<497:ASEITP>2.0.ZU;2-C
Abstract
We constructed a recombinant plasmid which expresses antisense src RNA
after dexamethasone (Dexa) treatment, and transfected it into U937 hu
man monoblastic leukemia cells (U937-ASRC). Induction of antisense src
RNA expression diminished the amounts of c-Src and its protein tyrosi
ne kinase (PTK) activity in U937-ASRC cells. The declines in c-Src and
its PTK activity subsequently reduced the proliferation of U937-ASRC
cells. To elucidate the growth signal transduction pathway downstream
of c-Src, tyrosine phosphorylation of She was examined in U937-ASRC ce
lls treated with Dexa. The decline in c-Src by induction of antisense
src RNA expression decreased the level of tyrosine phosphorylation of
She. Immunoprecipitated c-Src directly phosphorylated immunoprecipitat
ed She on tyrosine residues in vitro. The amounts of Grb2 and Sos coim
munoprecipitated with She were decreased after Dexa treatment. However
, the amount of Sos co-immunoprecipitated with Grb2 was apparently not
affected by Dexa treatment. These results indicate that Grb2 and Sos
constitutively associate with each other in U937 cells. Furthermore, t
he level of phosphorylation on tyrosine (204) essential for MAP kinase
activation was decreased after Dexa treatment. Taken together with al
l these findings, it is suggested that c-Src directly phosphorylates S
he on tyrosine residues, which in turn binds to Grb2 constitutively as
sociated with Sos to form a Shc-Grb2-Sos complex, and that the complex
formation is coupled with MAP kinase activation mediated by Ras activ
ation in U937 cells.